Year : 2011  |  Volume : 53  |  Issue : 3  |  Page : 183--186

Editorial policies aimed at improving the transparency and validity of published research


TS Sathyanarayana Rao1, Prathap Tharyan2,  
1 Department of Psychiatry, JSS University, JSS Medical College Hospital, M. G. Road, Mysore, Karnataka, India
2 South Asian Cochrane Centre, Prof. BV Moses & ICMR Centre for Advanced Research and Training in Evidence-Informed Healthcare, Christian Medical College, Vellore, Tamil Nadu, India

Correspondence Address:
T S Sathyanarayana Rao
Department of Psychiatry, JSS University, JSS Medical College Hospital, M. G. Road, Mysore - 570 004, Karnataka
India




How to cite this article:
Sathyanarayana Rao T S, Tharyan P. Editorial policies aimed at improving the transparency and validity of published research.Indian J Psychiatry 2011;53:183-186


How to cite this URL:
Sathyanarayana Rao T S, Tharyan P. Editorial policies aimed at improving the transparency and validity of published research. Indian J Psychiatry [serial online] 2011 [cited 2019 Sep 21 ];53:183-186
Available from: http://www.indianjpsychiatry.org/text.asp?2011/53/3/183/86793


Full Text

Research published in local and national journals, such as the Indian Journal of Psychiatry, is as important as research published in international journals, in order to contextualize the evidence on which healthcare and health policy needs are to be based. [1] However, the quality of research published in local and national journals, particularly those from low and middle-income countries, is often considered inferior to that of research articles published in international journals. [2] If these research findings are used to guide clinical practice, health outcomes may be adversely affected. Editorial policies, and adherence to these policies, determine to a large extent the quality of reporting of research published in journals. [3]

The duties of medical journal editors include, among others, safeguarding the rights of the study participants; establishing policies of submission, review and acceptance of manuscripts; and working towards improving the quality of the conduct and publication of research. [4] These can be aided by the unambiguous endorsement of standards that improve transparency in reporting research and by the provision of clear instructions to authors about what is expected of them. The instructions to authors in the Indian Journal of Psychiatry have therefore been amended to endorse internationally accepted reporting standards that are appropriate for the research design used. Authors of manuscripts are expected to adhere to these instructions when preparing manuscripts for submission in order to increase the chances that their manuscripts will be accepted. These amendments will also aid peer reviewers to readily identify whether the submitted manuscript meets the criteria for transparency in research reporting.

 Endorsing the ICMJE Uniform Requirements and use of Design-Specific Reporting Standards



The Indian Journal of Psychiatry continues to endorse the submission of manuscripts in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals of the International Committee of Medical Journal Editors (ICMJE); [5] the web-link to the ICMJE requirements has now been provided to enable authors to access the requirements in their entirety. The Uniform Requirements endorse design-specific reporting standards, and the revised instructions to authors now provide links to the appropriate guidance for interventional observational studies, and qualitative research, and for reports comparing the accuracy of diagnostic tests.

 Consort 2010



Authors of randomized clinical trials are now required not only to prepare and submit their manuscripts in accordance with the CONSORT 2010 statement, [6],[7] but also to use the appropriate extensions of the CONSORT statement for trial designs that differ from the standard parallel-group trial or that use herbal interventions, and on reporting harms. [8],[9],[10],[11],[12],[13] Authors are also expected to submit, along with the manuscript, the CONSORT checklist and participant flow diagram. The web-links to templates for both that can be downloaded and appropriately modified have also been provided. The former will not be published with the trial report but will aid effective peer review by stating exactly where in the manuscript the required CONSORT element can be found. The latter will be published and will provide information that will aid interpretation of the generalizability of the results by disclosing details of those excluded from the trial so that the reader can evaluate the proportions excluded, particularly for not fulfilling inclusion criteria. It will also disclose the proportions in each trial arm that completed the various stages of the trial, thus making it possible to evaluate if the analysis of the results was complete.

 Strobe



Most research published in this journal are observational in nature and authors are required to follow the guidance provided in the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement for reporting observational studies, typically cross-sectional studies, case-control studies and cohort studies. [14],[15] Authors of these manuscripts should also include in their submission the STROBE checklists, for which a link has been provided, to aid the peer-review process.

 Stard



Studies that evaluate the sensitivity, specificity, and other characteristics of a diagnostic test (including clinical criteria or a diagnostic scale) against a reference standard should follow the guidance provided in the STARD statement that aims to improve the accuracy and completeness of reporting of studies of diagnostic accuracy, in order to assess the potential for bias in the study (internal validity) and to evaluate its generalizability (external validity). [16] Manuscripts of diagnostic accuracy studies should also include the STARD checklist and a flow diagram for which a web-link has been provided. The flow diagram will be published with the report.

 Coreq



Qualitative research in psychiatry is common, but the quality of reporting of the results of surveys and focus group discussions is seldom uniform. The Journal now expects authors of manuscripts that describe qualitative research obtained from in-depth interviews and focus group discussions to follow the guidance found in the consolidated criteria for reporting qualitative research (COREQ criteria), and to submit the COREQ checklist with their submissions. [17]

 Prisma and Moose



Systematic reviews are reviews with clearly formulated questions and that use systematic and explicit methods to identify, select, and critically appraise relevant research and to extract and analyze data from the studies that are included in the review. Meta-analysis refers to the use of statistical techniques that may (or may not) be used in a systematic review to integrate the results of included studies. Manuscripts of systematic reviews of interventional studies should follow the guidance provided in the PRISMA statement. [18] Authors of manuscripts should include in their submission, the PRISMA checklist and flow diagram that can be downloaded from the web-link provided and that should be used in conjunction with the PRISMA explanation and elaboration document. If the systematic review and meta-analysis primarily includes observational studies, then the manuscript should be prepared in accordance with the MOOSE guidelines. [19]

 Enhancing the Quality and Transparency of Health Research : The Equator Network



The Equator Network is an international initiative that aims to improve the reporting of health research, and their website ( http://www.equator-network.org/ ) provides up-to-date resources aimed at empowering authors, editors, peer reviewers and developers of guidelines to improve the value and reliability of their research by improving transparent and accurate reporting. All the reporting standards endorsed herein, as well as many more resources aimed at improving the quality of research, can be accessed from the site. Research funders, research ethics committee members, individuals and organizations involved in research education will also find the resources collated in this site educative and informative.

 Using Reporting Guidelines to Improve the Quality of Published Research



Systematic surveys have demonstrated that the adoption and implementation of the CONSORT statement and checklist by international journals had improved the quality of reporting of randomized controlled trials over time, compared with journals that did not do so. [20],[21],[22] However, an analysis of the instructions to authors and of randomized controlled trials published in 65 Indian medical journals in 2004-2005 revealed that only a third of the journals endorsed the CONSORT statement and the quality of reporting of key CONSORT items, particularly those aimed at reducing the risk of bias in these trials, was sub-optimal. Adequacy of reporting was not related to whether the journal endorsed either the CONSORT statement or the ICMJE requirements. [23]

It is hoped that adherence to the CONSORT requirements would improve if the CONSORT checklist is made essential for authors to submit, and for peer-reviewers and editors to use while evaluating the manuscripts.

 Science and Ethics in Research



Research that is not free from bias and confounding is likely to lead to erroneous results; such research is unethical as it betrays the trust of participants and those using the results of research to guide policy and practice. Similarly, research involving humans that do not adhere to ethical principles is inexcusable. In accordance with the ICMJE Uniform Requirements, the Indian Journal of Psychiatry, in its expanded section on ethical issues in the instructions to authors, now provides web-links to the 2008 revision of the Declaration of Helsinki [24] and to the ethical guidelines of the Indian Council of Medical Research. [25] Authors are expected to have obtained ethical clearance from an authorized committee that has evaluated the scientific and ethical aspects of the proposed research, and that may be contacted directly, if thought necessary, for further clarifications. In adopting the ICMJE requirements, the Journal also endorses internationally approved policies on plagiarism, duplicate publications and research misconduct; declaring completing interests and funding sources; and on claiming authorship, that authors of manuscripts need to be cognizant of. [5]

 Facilitating Improvements in the Design of Research Protocols



Deficiencies in the quality of published research reports may reflect a poor understanding of research design; the reporting standards endorsed herein provide guidance on the elements considered essential to improve the internal and external validity of the study that will differ according to the research question and the study design adopted, apart from improving the transparency of the published report. As part of its editorial mandate to facilitate improvements in the quality of published research, the Journal advises authors to refer to the reporting guidelines specific to the design of the proposed study, particularly their elaboration and explanation documents, at the time the study is being designed. This will ensure that these elements were prospectively ascertained and hopefully would lead to better conduct, and better quality of reporting of the methods and the results of research.

 Prospective Registration of Clinical Trials



Apart from biases that arise due to flaws in the design and execution of research, reporting biases (wherein what is reported and how they are reported are determined by the study results, and what authors wish to conceal, reveal, misdirect, or highlight) also contribute to the erroneous interpretation of research results. [26] In February 2008, the editors of 11 Indian medical journals published a statement [27] endorsing the ICMJE and WHO position on expecting that all clinical trials assigning participants to one or more pharmacological or non-pharmacological interventions in order to improve health outcomes be prospectively registered before recruiting any participant, and essential details of the protocol be disclosed in a trials registry approved by the WHO. This statement set a deadline for January 2010 after which these journals intended to refuse manuscripts of interventional studies that had not been prospectively registered. The CONSORT 2010 checklist also requires prospective trials registration as a pre-requisite. [6],[7] The 2008 revision of the Declaration of Helsinki also requires, in clause 19, the prospective registration of clinical trials. [24] The Clinical Trials Registry - India (CTRI; www.ctri.nic.in ) is a primary register of the WHO International Clinical Trials Registry Platform and all trials prospectively registered in the CTRI will be accepted as fulfilling the ICMJE requirements. [28],[29] The Drug Controller General of India has made prospective registration of clinical trials in the CTRI as a regulatory requirement from July 2009, and this has led to an increase in the prospective registration of industry-sponsored trials. [30] The Clinical Practice Guidelines of the Indian Psychiatric Society on ethical issues in research recommended the prospective registration of clinical trials in India. [31] An analysis of trials registered in the CTRI indicated that the quality of reporting of items affecting internal validity was significantly better than that in reports published in Indian medical journals, suggesting that prospective trials' registration has the potential to not only detect reporting biases, but also improve the design of clinical trials by providing a template that researchers can use to improve trial protocols. [32]

In keeping with these international and national requirements, the Indian Journal of Psychiatry joins the fraternity of international and Indian journals that require authors to prospectively register clinical trials and to submit the registry identification details along with the manuscript. If the trial has recruited participants from sites in India, the Journal expects that the trial would have been prospectively registered in the CTRI. This requirement would become mandatory for all fresh submissions from January 1, 2013.

This slew of initiatives will help ensure that the standard of research published in the Indian Journal of Psychiatry, in its current avatar, reflects the aspirations and intentions of the editorial board of the Journal and the members of the Indian Psychiatric Society and serves as a vehicle for the publication of research on all aspects of mental health from India and around the World that is valid, transparent and relevant. This can be reliably used to improve clinical care, formulate clinical practice guidelines and health policies and improve the health outcomes of our patients.

References

1Ofori-Adjei D, Antes G, Tharyan P, Slade E, Tamber PS. Have online international medical journals made local journals obsolete? PLoS Med 2006;3:e359.
2Zhang D, Freemantle N, Cheng KK. Are randomized trials conducted in China or India biased? A comparative empirical analysis. J Clin Epidemiol 2011;64:90-5.
3Matarese V. Relationship between quality and editorial leadership of biomedical research journals: A comparative study of Italian and UK journals. PLoS One 2008;3:e2512.
4World Association of Medical Editors. Syllabus for prospective and newly appointed editors. Available from: http://www.wame.org/resources/editor-s-syllabus#responsibilities [Last cited on 2011 May 24].
5International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals (updated April 2010). Available from: http://www.icmje.org/urm_main.html [Last cited on 2011 May 24].
6Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332.
7Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trial. BMJ 2010;340:c869.
8Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ. Reporting of noninferiority and equivalence randomized trials: An extension of the CONSORT statement. JAMA 2006;295:1152-60.
9Campbell MK, Elbourne DR, Altman DG. CONSORT statement: extension to cluster randomised trials. BMJ 2004;328:702-8.
10Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, et al. Improving the reporting of pragmatic trials: An extension of the CONSORT statement. BMJ 2008;337:a2390.
11Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: Explanation and elaboration. Ann Intern Med 2008;148:295-309.
12Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med 2006;144:364-7.
13Ioannidis JP, Evans SJ, Gøtzsche PC, O'Neill RT, Altman DG, Schulz K, et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 2004;141:781-8.
14Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in Eeidemiology (STROBE) statement: Guidelines for reporting observational studies. Ann Intern Med 2007;147:573-7.
15Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, et al. STROBE Initiative. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Epidemiology 2007;18:805-35.
16Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et al. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med 2003;138:40-4.
17Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007;19:349-57.
18Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-Analyses: The PRISMA Statement. BMJ 2009;339:b2535.
19Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D,et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
20Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C, et al. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust 2006;185:263-7.
21Kane RL, Wang J, Garrard J. Reporting in randomized clinical trials improved after adoption of the CONSORT statement. J Clin Epidemiol 2007;60:241-9.
22Hopewell S, Dutton S, Yu LM, Chan AW, Altman DG. The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ 2010;340:c723.
23Tharyan P, Premkumar TS, Mathew V, Barnabas JP, Manuelraj. Editorial policy and the reporting of randomized controlled trials: a survey of instructions for authors and assessment of trial reports in Indian medical journals (2004-2005). Natl Med J India 2008;21:62-8.
24World Medical Association. WMA Declaration of Helsinki-Ethical principles for medical research involving human subjects (amended October 2008). Available from: http://www.wma.net/en/30publications/10policies/b3/index.html [Last cited on 2011 May 25].
25Indian Council of Medical Research. Ethical guidelines for biomedical research on human participants (revised in 2006). Available from: http://www.icmr.nic.in/ethical_guidelines.pdf [Last cited on 2011 May 25].
26Chan AW, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles. JAMA 2004;291:2457-65.
27Satyanarayana K, Sharma A, Parikh P, Vijayan VK, Sahu DK, Nayak BK, et al. Statement on publishing clinical trials in Indian biomedical journals. Indian J Med Res 2008;127:104-5.
28Tharyan P, Ghersi D. Registering clinical trials in India: a scientific and ethical imperative. Natl Med J India 2008;21:31-4.
29Pandey A, Aggarwal AR, Seth SD, Maulik M, Bano R, Juneja A. Clinical Trials Registry - India: Redefining the conduct of clinical trials. Indian J Cancer 2008;45:79-82.
30Pandey A, Aggarwal AR, Maulik M, Seth SD. Clinical Trials Registry-India: Raising the veil. Natl Med J India 2010;23:187-8.
31Tharyan P. Ethics in psychiatric research. Available from: http://www.indianjpsychiatry.org/cpg/cpg2009/article5.pdf [Last cited on 2011May 25].
32Tharyan P. Prospective registration of clinical trials in India: Strategies, Achievements and Challenges. J Evid Based Med 2009;1:19-28.